FDA Drug Recalls

Recalls / Class III

Class IIID-0499-2019

Product

Oxytocin 30 Units added to NS 500 mL (oxytocin and 0.9% Sodium Chloride) Injectable Solution, Approximately 503 mL Sterile single use bag, Rx only, Avella of Houston, 9265 Kirby Dr., Houston, TX 77054, NDC 42852-706-50.

Affected lot / code info
Lots: 11/27/18 3177 70650P, BUD: 02/10/2019; 11/27/18 6618 70650P, BUD: 02/10/2019; 11/28/18 7716 70650P, BUD: 02/12/19; 12/31/18 5698 70650P, BUD: 03/16/19

Why it was recalled

Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.

Recalling firm

Firm
Advanced Pharma Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
9265 Kirby Dr, Houston, Texas 77054-2520

Distribution

Quantity
1460 bottles
Distribution pattern
Nationwide in the USA.

Timeline

Recall initiated
2019-02-06
FDA classified
2019-02-15
Posted by FDA
2019-02-27
Terminated
2019-10-30
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0499-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: drug · FDA Drug Recalls